Moch H - Search Results

1

Fullerenols and glucosamine fullerenes reduce infarct volume and cerebral inflammation after ischemic stroke in normotensive and hypertensive rats.

Fluri F, Grünstein D, Cam E, Ungethuem U, Hatz F, Schäfer J, Samnick S, Israel I, Kleinschnitz C, Orts-Gil G, Moch H, Zeis T, Schaeren-Wiemers N, Seeberger P. Fluri F, et al. Among authors: moch h. Exp Neurol. 2015 Mar;265:142-51. doi: 10.1016/j.expneurol.2015.01.005. Epub 2015 Jan 24. Exp Neurol. 2015. PMID: 25625851

2

VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma.

Schraml P, Struckmann K, Hatz F, Sonnet S, Kully C, Gasser T, Sauter G, Mihatsch MJ, Moch H. Schraml P, et al. Among authors: moch h. J Pathol. 2002 Feb;196(2):186-93. doi: 10.1002/path.1034. J Pathol. 2002. PMID: 11793370

3

Relevance of nuclear and cytoplasmic von hippel lindau protein expression for renal carcinoma progression.

Schraml P, Hergovich A, Hatz F, Amin MB, Lim SD, Krek W, Mihatsch MJ, Moch H. Schraml P, et al. Among authors: moch h. Am J Pathol. 2003 Sep;163(3):1013-20. doi: 10.1016/s0002-9440(10)63461-x. Am J Pathol. 2003. PMID: 12937142 Free PMC article.

4

TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.

Rechsteiner M, Zimmermann AK, Wild PJ, Caduff R, von Teichman A, Fink D, Moch H, Noske A. Rechsteiner M, et al. Among authors: moch h. Exp Mol Pathol. 2013 Oct;95(2):235-41. doi: 10.1016/j.yexmp.2013.08.004. Epub 2013 Aug 18. Exp Mol Pathol. 2013. PMID: 23965232

5

Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07.

Schraml P, von Teichman A, Mihic-Probst D, Simcock M, Ochsenbein A, Dummer R, Michielin O, Seifert B, Schläppi M, Moch H, von Moos R. Schraml P, et al. Among authors: moch h. Oncol Rep. 2012 Aug;28(2):654-8. doi: 10.3892/or.2012.1826. Epub 2012 May 18. Oncol Rep. 2012. PMID: 22614944

6

p53 and erbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancer.

Moch H, Sauter G, Moore D, Mihatsch MJ, Gudat F, Waldman F. Moch H, et al. Virchows Arch A Pathol Anat Histopathol. 1993;423(5):329-34. doi: 10.1007/BF01607144. Virchows Arch A Pathol Anat Histopathol. 1993. PMID: 7509541

7

[Ki-67 fraction, p53 alteration and numerical chromosome aberrations (chromosomes 7 and 17) in formalin fixed bladder tumors].

Moch H, Sauter G, Gudat F, Waldman F, Mihatsch MJ. Moch H, et al. Verh Dtsch Ges Pathol. 1993;77:226-30. Verh Dtsch Ges Pathol. 1993. PMID: 7511286 German.

8

[Demonstration of gene amplification in urinary bladder cancer by fluorescent in situ hybridization (FISH)].

Sauter G, Moch H, Gudat F, Mihatsch MJ, Haley J, Meecker T, Waldman F. Sauter G, et al. Among authors: moch h. Verh Dtsch Ges Pathol. 1993;77:247-51. Verh Dtsch Ges Pathol. 1993. PMID: 7511290 German.

9

Chromosome-9 loss detected by fluorescence in situ hybridization in bladder cancer.

Sauter G, Moch H, Carroll P, Kerschmann R, Mihatsch MJ, Waldman FM. Sauter G, et al. Among authors: moch h. Int J Cancer. 1995 Apr 21;64(2):99-103. doi: 10.1002/ijc.2910640205. Int J Cancer. 1995. PMID: 7615360

10

Clinical and pathological features of highly malignant prostatic carcinomas with metastases to the penis.

Buchholz NP, Moch H, Feichter GE, Schmid HP, Mihatsch MJ. Buchholz NP, et al. Among authors: moch h. Urol Int. 1994;53(3):135-8. doi: 10.1159/000282654. Urol Int. 1994. PMID: 7645139

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

728 results

Search Page

Filters